MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED)

Summary

To assess the efficacy of MK0524 on seasonal allergies.

Timeline

Start

2003-07

Primary completion

2003-10

Completion

2003-10

Outcome

Missed primary endpoint

paper For AR, although cetirizine (vs placebo) demonstrated an improvement in the Daytime Nasal Symptoms Score (P < .001), laropiprant did not. PMID 19748656 ↗

Publications

• Philip G, van Adelsberg J, Loeys T, Liu N, Wong P, Lai E, Dass SB, Reiss TF. Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis. J Allergy Clin Immunol. 2009 Nov;124(5):942-8.e1-9. doi: 10.1016/j.jaci.2009.07.006. Epub 2009 Sep 12.

Drugs

Indications